VVUS : NASDAQ : Health Technology
$0.4345 -0.0154 | -3.42%
Today's Range: 0.43 - 0.4579
Avg. Daily Volume: 697800.0
03/22/18 - 4:00 PM ET

Financial Analysis

VIVUS INC's gross profit margin for the third quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. VIVUS INC is extremely liquid. Currently, the Quick Ratio is 6.99 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has increased from the same period last year.

At the same time, stockholders' equity ("net worth") has greatly increased by 100.93% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.

Income Statement Q3 FY17 Q3 FY16
Net Sales ($mil)15.1913.35
EBITDA ($mil)2.58-0.59
EBIT ($mil)2.43-0.85
Net Income ($mil)-5.99-9.15

Balance Sheet Q3 FY17 Q3 FY16
Cash & Equiv. ($mil)236.02283.59
Total Assets ($mil)266.74313.15
Total Debt ($mil)234.71238.89
Equity ($mil)0.36-38.11

Profitability Q3 FY17 Q3 FY16
Gross Profit Margin77.8986.47
EBITDA Margin16.98-4.41
Operating Margin15.97-6.35
Sales Turnover0.510.18
Return on Assets13.54-14.51
Return on Equity10176.610.0
Debt Q3 FY17 Q3 FY16
Current Ratio7.472.71
Interest Expense9.08.8
Interest Coverage0.27-0.1

Share Data Q3 FY17 Q3 FY16
Shares outstanding (mil)105.86104.82
Div / share0.00.0
Book value / share0.0-0.36
Institutional Own % n/a n/a
Avg Daily Volume721895.0688092.0


SELL. VIVUS INC's P/E ratio indicates a significant discount compared to an average of 105.10 for the Pharmaceuticals industry and a significant discount compared to the S&P 500 average of 25.66. For additional comparison, its price-to-book ratio of 145.45 indicates a significant premium versus the S&P 500 average of 3.28 and a significant premium versus the industry average of 7.60. The price-to-sales ratio is well below both the S&P 500 average and the industry average, indicating a discount. The valuation analysis reveals that, VIVUS INC seems to be trading at a discount to investment alternatives within the industry.

1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
VVUS 1.41 Peers 105.10   VVUS NM Peers 17.82

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

VVUS is trading at a significant discount to its peers.


Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

VVUS's P/CF is negative making the measure meaningless.

1 2 3 4 5
premium   discount
  Price to
1 2 3 4 5
premium   discount
VVUS NM Peers 14.20   VVUS NM Peers 0.51

Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.

VVUS's ratio is negative making this valuation measure meaningless.


Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

VVUS's negative PEG ratio makes this valuation measure meaningless.

1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
VVUS 145.45 Peers 7.60   VVUS 177.27 Peers -278.29

Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

VVUS is trading at a significant premium to its peers.


Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

VVUS is expected to have an earnings growth rate that significantly exceeds its peers.

1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
VVUS 0.38 Peers 25.39   VVUS 133.99 Peers 23.77

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

VVUS is trading at a significant discount to its industry on this measurement.


Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

VVUS has a sales growth rate that significantly exceeds its peers.



Latest Stock Upgrades/Downgrades